Physician profile
Jonathan Cotton
NPI 1639187446
$2,196.66
in general payments reported to CMS, 2019-2025
14 companies · $187 in 2025
The $187 reported for 2025 was more than what 88% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $587 · 2023: $735 · 2024: $563 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.10 | 2023-2025 | |
| Novo Nordisk INC | $250.00 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.79 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $237.60 | 2023-2024 | Rexulti |
| Sage Therapeutics, LLC | $201.30 | 2023 | |
| Lundbeck LLC | $124.99 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $124.49 | 2023 | Austedo Xr |
| Inspire Medical Systems, INC. | $111.60 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $101.19 | 2024 | Xarelto |
| Eisai INC. | $94.26 | 2022 | |
| Dexcom, INC. | $89.97 | 2024 | Dexcom G7 Gss (161) |
| Vertex Pharmaceuticals Incorporated | $87.77 | 2025 | |
| Paratek Pharmaceuticals, INC. | $86.78 | 2023 | Nuzyra |
| Rayner Intraocular Lenses Limited | $24.82 | 2024 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.